Skip to main content
. Author manuscript; available in PMC: 2011 Sep 21.
Published in final edited form as: Bioorg Med Chem Lett. 2008 Sep 11;18(20):5443–5447. doi: 10.1016/j.bmcl.2008.09.032

Scheme 1.

Scheme 1

Reagents: (a) R1COCl, PS-DIEA, 85–88%; (b) MP-B(OAc)3H, 4-(2-keto-1-benzoimidazolinyl)piperidine or 5-chloro-1-(4-piperidinyl)-2-benzimidazolone, DCM, rt, 24 hr, 85–95%. All compounds purified by mass-directed HPLC to analytical purity (>98%).